Join our LinkedIn PATENTSCOPE users Community Group
Feedback
Settings

Settings

Goto Application

1,349,266 results
Offices all Languages en Stemming true Single Family Member false Include NPL false
RSS feed can only be generated if you have a WIPO account

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents
Include Non-Patent literature in results

Full Query

(NPCC:US AND CTR:WO)

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1 / 134,927
1.WO/2002/000711EV-VEGF NUCLEIC ACIDS AND POLYPEPTIDES AND METHODS OF USE
WO - 03.01.2002
Int.Class A61K 31/7088
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
7088Compounds having three or more nucleosides or nucleotides
 Appl.No PCT/US2001/020116 Applicant GENENTECH, INC. Inventor FERRARA, Napoleone
The present invention is directed to novel polypeptides designated herein as EG-VEGF and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. Also provided herein are methods of screening for modulators of EG-VEGF. Furthermore, methods and related methods of treatment are described herein which pertain to regulating cellular proliferation and chemotaxis.
2.WO/2002/008288SECRETED AND TRANSMEMBRANE POLYPEPTIDES AND NUCLEIC ACIDS ENCODING THE SAME
WO - 31.01.2002
Int.Class C07H 21/00
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
21Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
 Appl.No PCT/US2001/021066 Applicant GENENTECH, INC. Inventor BAKER, Kevin, P.
The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
3.WO/2002/000690COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF DISORDERS INVOLVING ANGIOGENESIS
WO - 03.01.2002
Int.Class A61K 38/17
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
 Appl.No PCT/US2001/019692 Applicant GENENTECH, INC. Inventor BAKER, Kevin, P.
Compositions and methods are disclosed for stimulating or inhibiting angiogenesis and/or cardiovascularization in mammals, including humans. Pharmaceutical compositions are based on polypeptides or antagonists thereto that have been identified for one or more of these uses. Disorders that can be diagnosed, prevented, or treated by the compositions herein include trauma such as wounds, various cancers, and disorders of the vessels including atherosclerosis and cardiac hypertrophy.In addition, the present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
4.WO/2000/067665SUPPORT FRAME FOR EMBOLIC PROTECTION DEVICE
WO - 16.11.2000
Int.Class A61F 2/01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
2Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
01Filters implantable into blood vessels
 Appl.No PCT/IE1999/000035 Applicant SALVIAC LIMITED Inventor GILSON, Paul
A support frame (30) for an embolic protection filter (31). Three arms (20, 21, 22) provide support for a proximal end of the filter body (31) and three arms (23, 24, 25) provide support for a distal end of the filter body (31). In this many loading and deployment forces are reduced.
5.WO/2002/024888SECRETED AND TRANSMEMBRANE POLYPEPTIDES AND NUCLEIC ACIDS ENCODING THE SAME
WO - 28.03.2002
Int.Class A61K 38/17
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
 Appl.No PCT/US2001/027099 Applicant GENENTECH, INC. Inventor BAKER, Kevin P.
The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
6.WO/1999/035170COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR
WO - 15.07.1999
Int.Class C07K 14/47
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435from animals; from humans
46from vertebrates
47from mammals
 Appl.No PCT/US1999/000106 Applicant GENENTECH, INC. Inventor BOTSTEIN, David
The invention concerns compositions and methods for the diagnosis and treatment of neoplastic cell growth and proliferation in mammals, including humans. The invention is based on the identification of genes that are amplified in the genome of tumor cells. Such gene amplification is expected to be associated with the overexpression of the gene product and contribute to tumorigenesis. Accordingly, the proteins encoded by the amplified genes are believed to be useful targets for the diagnosis and/or treatment (including prevention) of certain cancers, and may act of predictors of the prognosis of tumor treatment.
7.WO/2002/051329TENDON ACTUATED ARTICULATED MEMBERS FOR A TELEMANIPULATOR SYSTEM
WO - 04.07.2002
Int.Class A61B 19/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
BDIAGNOSIS; SURGERY; IDENTIFICATION
19Instruments, implements or accessories for surgery or diagnosis not covered by any of the groups A61B1/-A61B18/149
 Appl.No PCT/US2001/011376 Applicant ENDOVIA MEDICAL INC Inventor BROCK, David, L.
An articulated apparatus is disclosed that includes a first link member (82), a second link member (76), and a third link member (24). The second link member (76) is coupled to the first link member (82) at a proximal end of the second link member (76) by a first joint (34) having a first axis of rotation. The third link member (24) is coupled to a distal end of the second link member (76) by a second joint (30). The movement of the third link member (24) with respect to the second link member (76) is governed by at least one tendon (64) that passes through the first axis of rotation of the first joint (34) that movement of the second member (76) with respect to the first member (82) does not cause movement of the third member (24) with respect to the second member (76).
8.WO/2000/002213NON-SYMMETRIC CAPACITOR
WO - 13.01.2000
Int.Class H01G 4/32
HELECTRICITY
01BASIC ELECTRIC ELEMENTS
GCAPACITORS; CAPACITORS, RECTIFIERS, DETECTORS, SWITCHING DEVICES, LIGHT-SENSITIVE OR TEMPERATURE-SENSITIVE DEVICES OF THE ELECTROLYTIC TYPE
4Fixed capacitors; Processes of their manufacture
32Wound capacitors
 Appl.No PCT/US1999/015207 Applicant AEROVOX, INC. Inventor HUDIS, Martin
A capacitor having an electrochemical cathode electrode (54), an electrolytic anode electrode (52), and a substantially non-aqueous electrolyte disposed between the cathode and anode electrodes. The cathode includes a metal and a finely divided material, i.e. a conducting material with a very high ratio of surface area to volume. The anode includes an oxide forming metal and a corresponding metal oxide. The substantially non-aqueous electrolyte is in contact with the finely divided material forming a double layer electrochemical cathode capacitor. The cathode provides the foundation for interleaving a plurality of anodes with a plurality of cathodes. Insulating layers separate the interleaved anodes from the cathodes.
9.WO/1999/046281NOVEL POLYPEPTIDES AND NUCLEIC ACIDS ENCODING THE SAME
WO - 16.09.1999
Int.Class A61K 38/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
 Appl.No PCT/US1999/005028 Applicant GENENTECH, INC. Inventor WOOD, William, I.
10.WO/2002/019147METHOD AND APPARATUS FOR DIGITAL MEDIA MANAGEMENT, RETRIEVAL, AND COLLABORATION
WO - 07.03.2002
Int.Class G06F 17/30
GPHYSICS
06COMPUTING; CALCULATING OR COUNTING
FELECTRIC DIGITAL DATA PROCESSING
17Digital computing or data processing equipment or methods, specially adapted for specific functions
30Information retrieval; Database structures therefor
 Appl.No PCT/US2001/026841 Applicant EMOTION, INC. Inventor FLANK, Sharon
The software according to the invention incorporates a glossary management tool (fig. 2) that makes it easy for each client to customize terminology (fig. 2) to the needs of a particular business. With this tool, termed a glossary manager (fig. 2), a company can customize a number of feature names (fig. 2) in the system to provide a more familiar context (fig. 2) for their users. A system administrator can also customize the manner in which 'thumbnail' or 'preview' images (fig. 2) are presented. The system performs clustering on search queries, and searches media records multi-modally, using two or more approaches such as image searching and text searching. An administrator can tune search parameters. Two or more streams of metadata may be aligned and correlated with a media file, facilitating later searching. The system evaluates itself. It folds popularity information into rankings of search results.
# -